The recepteur d’origne nantais (RON) is a receptor tyrosine kinase (RTK) in the scatter factor family, which includes the c-Met receptor. RON exhibits increased expression in a significant number of human breast cancer tissues as well as in many established breast cancer cell lines. Recent studies have indicated that in addition to ligand-dependent signaling events, RON also promotes signals in the absence of its only known ligand, the macrophage stimulating protein, when expressed in epithelial cells. In the current study, we found that when expressed in MCF-10A breast epithelial cells, RON exhibits both MSP-dependent and MSP-independent signaling, which lead to distinct biological outcomes. In the absence of MSP, RON signaling promotes ce...
Introduction: Aberrant RON (Recepteur d'Origine Nantais) tyrosine kinase activation causes the epith...
AbstractIntroductionAberrant RON (Recepteur d'Origine Nantais) tyrosine kinase activation causes the...
Metastasis is the major cause of death in cancer patients, yet the genetic and epigenetic programs t...
The recepteur d’origne nantais (RON) is a receptor tyrosine kinase (RTK) in the scatter factor famil...
This study focuses on the RON receptor expression in two breast cancer cell lines using three method...
The MST1R/RON receptor tyrosine kinase is a homologue of the more well-known MET receptor. Like MET,...
The receptor tyrosine kinase Ron and its ligand, Macrophage Stimulating Protein (MSP), mediate multi...
Although tamoxifen treatment is associated with improved survival in patients with estrogen receptor...
thesisMetastasis remains the leading cause of death in breast cancer patients, and the lack of curat...
Triple negative breast cancer (TNBC) is the most aggressive subtype of breast cancer with poor progn...
RON is a transmembrane receptor tyrosine kinase that mediates biological activities of Macrophage St...
RON is a receptor tyrosine kinase (RTK) of the MET receptor family that is canonically involved in m...
Receptors for the scatter factors HGF and MSP that are encoded by the MET and RON oncogenes are key ...
RON is a tyrosine kinase receptor that triggers scattering of normal cells and invasive growth of c...
Abstract: The recepteur d’origine nantais (RON) is a member of MET family of receptor tyrosine kinas...
Introduction: Aberrant RON (Recepteur d'Origine Nantais) tyrosine kinase activation causes the epith...
AbstractIntroductionAberrant RON (Recepteur d'Origine Nantais) tyrosine kinase activation causes the...
Metastasis is the major cause of death in cancer patients, yet the genetic and epigenetic programs t...
The recepteur d’origne nantais (RON) is a receptor tyrosine kinase (RTK) in the scatter factor famil...
This study focuses on the RON receptor expression in two breast cancer cell lines using three method...
The MST1R/RON receptor tyrosine kinase is a homologue of the more well-known MET receptor. Like MET,...
The receptor tyrosine kinase Ron and its ligand, Macrophage Stimulating Protein (MSP), mediate multi...
Although tamoxifen treatment is associated with improved survival in patients with estrogen receptor...
thesisMetastasis remains the leading cause of death in breast cancer patients, and the lack of curat...
Triple negative breast cancer (TNBC) is the most aggressive subtype of breast cancer with poor progn...
RON is a transmembrane receptor tyrosine kinase that mediates biological activities of Macrophage St...
RON is a receptor tyrosine kinase (RTK) of the MET receptor family that is canonically involved in m...
Receptors for the scatter factors HGF and MSP that are encoded by the MET and RON oncogenes are key ...
RON is a tyrosine kinase receptor that triggers scattering of normal cells and invasive growth of c...
Abstract: The recepteur d’origine nantais (RON) is a member of MET family of receptor tyrosine kinas...
Introduction: Aberrant RON (Recepteur d'Origine Nantais) tyrosine kinase activation causes the epith...
AbstractIntroductionAberrant RON (Recepteur d'Origine Nantais) tyrosine kinase activation causes the...
Metastasis is the major cause of death in cancer patients, yet the genetic and epigenetic programs t...